AGTX — Agentix Corp.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1603345 ·
Last close
$0.02
Market Cap
$801.3K
52W High
$0.04
52W Low
$0.01
ADV30
9,822
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -54,285 | -77,110 | 771 | 771 | 3,596,282 |
| Dec 2025 | 0 | — | -67,463 | -78,595 | 6,396 | 6,396 | 3,504,396 |
| Sep 2025 | 0 | — | -123,097 | -144,107 | 5,601 | 5,601 | 3,423,639 |
| Jun 2025 | 0 | — | -200,342 | -185,824 | 4,412 | 4,412 | 3,276,178 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-108,529
Investing CF
$0
Financing CF
$110,450
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-07-05
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,007,164
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-405,530
Pretax Income TTM
$-485,636
Interest Exp TTM
$80,106
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -445,187 | -485,636 | 771 | 3,596,282 | — | -108,529 |
| Mar 2025 | 0 | -513,251 | -567,048 | 100,274 | 3,204,523 | — | -125,078 |
| Mar 2024 | 0 | -744,810 | -585,154 | 106,372 | 2,666,594 | — | -110,429 |
| Mar 2023 | 0 | -1,371,756 | -1,373,805 | 261,392 | 2,510,555 | — | -88,541 |
| Aug 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VIVS | VivoSim Labs, INC. | $1.19M | $0.34 | — |
| ABPO | Abpro Holdings, Inc. | $1.24M | $0.21 | — |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.41M | $0.27 | — |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | $451.1K | $0.01 | — |
| CPMV | Mosaic ImmunoEngineering Inc. | $434.5K | $0.06 | — |
Recent Insider Activity
No insider activity indexed for this ticker.